Search results for " biotechnology" in Articles / App Notes
Article
Using Quality by Design to Develop Robust Chromatographic Methods
Quality-by-design principles can be used to understand chromatographic measurement system variability.
Sep 2, 2014
By: Melissa Hanna-Brown, Kimber Barnett, Brent Harrington, Tim Graul, Jim…
Article
Healthcare Reform in China
The biotechnology sector is another key development that companies can look to explore. The Chinese government has invested $1.6 billion to support major new drug innovations from 2011 to 2015, focusi…
Article
Concentrating Feed—an Applicable Approach to Improve Antibody Production
The gene functions were obtained from the website of the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov/gene).
Results
Concentrated feed medium M1 test in shake flask…
Article
Q&As with Industry Leaders
Karol Lacki, Customer Collaborations Leader, Cytiva
The Role of HIC in Biotech
Professor Alois Jungbauer, Department of Biotechnol…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
International companies tend to form partnerships with local pharmaceutical or biotechnology firms to more easily access emerging markets. One such example is the Product Development Partnerships in B…
Article
Manufacturers Struggle with Breakthrough Drug Development
Emanuela Lacana of CDER’s Office of Biotechnology Products explained further at CASSS’ CMC Strategy Forum (Jan. 27, 2014) that breakthrough drug development requires information on critical quality at…
Article
EMA Collaborates with HTA Assessment Networks
“SMEs are generally interested in receiving joint EMA/HTA advice, in particular when it comes to advanced therapies,” says Paolo Morgese, chairman of the HTA Topic Group of EuropaBio, a biotechnology …
Article
Brazil Emerges as Global Biopharm Collaborator
According to Abifina, Brazil’s Fine Chemicals, Biotechnology, and Specialty Industries Association, Latin American countries are still planting seeds to develop and compete in the global biopharmaceut…
Article
Comparing Protein A Resins for Monoclonal Antibody Purification
In 2007, mAbs accounted for almost half of the top-20 best-selling biotechnology drugs in the US alone, establishing them as an important group of molecules (3). Today, mAbs constitute the single larg…
Article
Supplier-Change Management for Drug-Product Manufacturers
Pharmaceutical and biotechnology companies making products for human use have an obligation to ensure that their products are safe, effective, meet established regulatory expectations and licenses, an…